Lidocaine Hydrochloride

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride, is an amide-type local anesthetic presented as a sterile injectable solution for epidural, intramuscular, and intravenous use. It provides rapid onset of local anesthesia and is employed in surgical, dental, and diagnostic procedures to manage pain in adult patients.

GNH USA supplies Lidocaine Hydrochloride as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on reliable quality, regulatory compliance and timely global logistics, and comprehensive customer support.

Lidocaine Hydrochloride is used to achieve local or regional anesthesia by blocking nerve conduction in various clinical settings.

- Surgical anesthesia: produces rapid, reversible loss of sensation at the operative site, facilitating painless procedures. - Dental procedures: enables effective numbing of oral tissues during extractions, restorations and periodontal work. - Diagnostic procedures: provides patient comfort during endoscopic, catheter‑based or imaging‑guided interventions. - Acute pain management: offers temporary relief of localized pain following trauma or minor surgery. - Post‑operative pain control: reduces discomfort in the immediate recovery period after operative interventions.

Lidocaine Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site - Mild dizziness or light‑headedness - Metallic taste in the mouth - Transient hypotension or mild bradycardia - Nausea or vomiting - Localized swelling or erythema

Serious or Rare Side Effects: - Seizures or convulsions - Cardiac arrhythmias, including ventricular tachycardia - Severe allergic reactions such as anaphylaxis - Methemoglobinemia leading to cyanosis - Respiratory depression - Persistent neurologic deficits (rare)

When using Lidocaine Hydrochloride, clinicians should observe several safety measures.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular status: monitor patients with pre‑existing heart disease or conduction abnormalities. - Dosage limits: adhere to recommended maximum dose to avoid systemic toxicity. - Concurrent CNS depressants: use caution when combined with other agents that depress the central nervous system. - Pregnancy and lactation: evaluate risk‑benefit; limited safety data are available. - Store below 25°C: keep in original container, protect from light and moisture.

Lidocaine Hydrochloride can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma lidocaine levels and risk of cardiotoxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic exposure. - Beta‑adrenergic blockers: may potentiate lidocaine‑induced bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive toxicity risk when used together. - Central nervous system depressants (e.g., benzodiazepines, opioids): may enhance sedation and respiratory depression.